These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3452820)

  • 1. The Framingham Heart Study--thirty years.
    Castelli WP
    Med Sect Proc; 1987; ():103-14. PubMed ID: 3452820
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum lipid fractions and risk of coronary heart disease. The Framingham study.
    Kannel WB; Castelli WP; McNamara PM
    Minn Med; 1969 Aug; 52(8):1225-30. PubMed ID: 5804989
    [No Abstract]   [Full Text] [Related]  

  • 3. [Framingham Study].
    Yoshinari M
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():381-6. PubMed ID: 11347099
    [No Abstract]   [Full Text] [Related]  

  • 4. Cigarette smoking and risk of coronary heart disease. Epidemiologic clues to pathogensis. The Framingham Study.
    Kannel WB; Castelli WP; McNamara PM
    Natl Cancer Inst Monogr; 1968 Jun; 28():9-20. PubMed ID: 5671419
    [No Abstract]   [Full Text] [Related]  

  • 5. The Framingham study of coronary disease in women.
    Kannel WB; Castelli WP
    Med Times; 1972 May; 100(5):173-5 passim. PubMed ID: 4338292
    [No Abstract]   [Full Text] [Related]  

  • 6. The Framingham Heart Study: review of epidemiological design and data, limitations and prospects.
    Higgins MW
    Prog Clin Biol Res; 1984; 147():51-64. PubMed ID: 6739495
    [No Abstract]   [Full Text] [Related]  

  • 7. Profile of the coronary-prone individual. Assessment of risk of developing coronary heart disease. The Framingham study.
    Kannel WB; Castelli WP; Revotskie N; McNamara PM
    Proc Annu Meet Med Sect Am Life Conv; 1967; 55():74-99. PubMed ID: 5633266
    [No Abstract]   [Full Text] [Related]  

  • 8. Thirty years of attempts to reduce coronary heart disease: new proposals.
    Nour-Eldin F
    Eur J Med; 1992 Oct; 1(6):358-61. PubMed ID: 1341464
    [No Abstract]   [Full Text] [Related]  

  • 9. The Framingham Heart Study shows no increases in coronary heart disease rates from cholesterol values of 205 to 264 mg%.
    Seltzer CC
    G Ital Cardiol; 1991 Jun; 21(6):683. PubMed ID: 1743450
    [No Abstract]   [Full Text] [Related]  

  • 10. Framingham Heart Study: review of genetic data and design, limitations and prospects.
    Namboodiri KK
    Prog Clin Biol Res; 1984; 147():65-78. PubMed ID: 6739497
    [No Abstract]   [Full Text] [Related]  

  • 11. State of the art coronary heart disease risk estimations based on the Framingham heart study.
    Reissigová J; Tomecková M
    Cent Eur J Public Health; 2005 Dec; 13(4):180-6. PubMed ID: 16419382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prospective study on coronary heart disease in Manresa: 15-year follow-up].
    Tomás Abadal L
    Rev Clin Esp; 1987 Jan; 180(1):4-7. PubMed ID: 3562969
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score.
    Albert MA; Glynn RJ; Ridker PM
    Circulation; 2003 Jul; 108(2):161-5. PubMed ID: 12835213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case-control analysis of the Prospective Cardiovascular Münster (PROCAM) study.
    Assmann G; Cullen P; Erbey J; Ramey DR; Kannenberg F; Schulte H
    Nutr Metab Cardiovasc Dis; 2006 Jan; 16(1):13-21. PubMed ID: 16399487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shellfish consumption and risk of coronary heart disease.
    Matheson EM; Mainous AG; Hill EG; Carnemolla MA
    J Am Diet Assoc; 2009 Aug; 109(8):1422-6. PubMed ID: 19631050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Framingham Study: sample selection, follow-up, and methods of analyses.
    Feinleib M
    Natl Cancer Inst Monogr; 1985 May; 67():59-64. PubMed ID: 4047152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk factors between blood cholesterol and coronary disease].
    Menotti A; Farchi G; Conti S
    G Ital Cardiol; 1985 Jun; 15(6):579-81. PubMed ID: 4065475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High risk for coronary heart disease in Thiruvananthapuram city: a study of serum lipids and other risk factors.
    Joseph A; Kutty VR; Soman CR
    Indian Heart J; 2000; 52(1):29-35. PubMed ID: 10820930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comments to the interpretation of the Framingham study].
    Oberwittler W
    Med Welt; 1968 Nov; 45():2478-80. PubMed ID: 5731112
    [No Abstract]   [Full Text] [Related]  

  • 20. Predicting coronary heart disease risk using the Framingham and PROCAM equations in dyslipidaemic patients without overt vascular disease.
    Vrentzos GE; Papadakis JA; Ganotakis ES; Paraskevas KI; Gazi IF; Tzanakis N; Nair DR; Mikhailidis DP
    Int J Clin Pract; 2007 Oct; 61(10):1643-53. PubMed ID: 17877651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.